The Liver Institute at Methodist Dallas Medical Center — Dallas, Texas

The Liver Institute at Methodist Dallas Medical Center is a clinical research site located in Dallas, Texas, United States 75203.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

The Liver Institute at Methodist Dallas Medical Center has participated in 42 clinical trials with 9 currently active.

Therapeutic areas: Alcohol Hepatitis, Compensated Cirrhosis, Nonalcoholic Steatohepatitis.

Sponsors: Aldeyra Therapeutics, Inc., Intercept Pharmaceuticals, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Liver Institute at Methodist Dallas Medical Center?

The Liver Institute at Methodist Dallas Medical Center has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Liver Institute at Methodist Dallas Medical Center conducted?

The Liver Institute at Methodist Dallas Medical Center has 42 clinical trials on record, with 9 currently active. Their work covers Alcohol Hepatitis, Compensated Cirrhosis, Nonalcoholic Steatohepatitis.

Is The Liver Institute at Methodist Dallas Medical Center accredited by Crixeo Clinical Trials?

The Liver Institute at Methodist Dallas Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Liver Institute at Methodist Dallas Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.